Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-31

Clinical Trial Update: Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial comparing injectable fentanyl given sublingually versus oral morphine syrup for breakthrough pain has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fentanyl (injectable, sublingual route) (fentanyl)
  • Morphine syrup (oral) (morphine)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Pain, Breakthrough | Phase 1, Phase 2 | Status: COMPLETED